timothy sykes logo
PATH Stock Steadies As UiPath Leans Into AI Control Plane Story Thumbnail
G Google News

PATH Stock Steadies As UiPath Leans Into AI Control Plane Story

TIM SYKES•UPDATED SEP. 14, 2026, 12:33 PM ET
Reviewed by Jack Kelloggand Fact-checked by Ellis Hobbs

UiPath Inc. stocks have been trading up by 7.38 percent following upbeat AI automation demand driving stronger growth expectations.

Key Takeaways Traders Need To Know

  • Q2 FY27 revenue grew 13% year over year to about $410M, with ARR at $1.94B and gross margins above 80%, all topping guidance and keeping PATH profitable on a GAAP and non-GAAP basis.
  • Full-year FY27 revenue guidance nudged up to $1.789B–$1.794B and ARR to $2.065B–$2.07B, modestly ahead of prior outlook and Street numbers, signaling steady mid-teens growth confidence.
  • Citi started coverage with a Buy rating and a $23 price target, framing PATH as a key “control plane” for enterprise AI and calling the post-earnings pullback an attractive entry on weakness.
  • RBC Capital, BMO Capital, and Barclays each raised their PATH price targets after the beat-and-raise quarter, citing AI-driven deal momentum and better enterprise traction, while keeping neutral-weight style ratings.
  • UiPath is pushing deeper into AI automation with Maestro Case and Maestro Flow, a scaled PLDT telecom deployment, and a refreshed leadership bench including a new CFO and a board member focused on enterprise transformation.

Candlestick Chart

Live Update At 12:32:48 EDT: On Monday, September 14, 2026 UiPath Inc. stock [NYSE: PATH] is trending up by 7.38%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

UiPath and its PATH ticker have been on a wild ride the past few weeks. The stock broke down from the $18s on 2026/09/03–2026/09/04 to the mid-teens, then slid into the low-$14s before bouncing to a 14.765 close on 2026/09/14. That is a hard reset of expectations, even after a beat-and-raise earnings print.

Under the hood, PATH is not some story-only AI play. Q2 FY27 revenue came in at $410.3M, up 13% year over year, with gross margin near 83%. Operating income was positive at $31.6M, and net income reached $36.1M, giving PATH a profit margin near 20%. Annualized, trailing revenue is roughly $1.61B, while the enterprise value sits around $5.96B, implying a price-to-sales ratio near 4.3 — not cheap, but reasonable for profitable mid-teens growth in AI automation.

More Breaking News

The balance sheet is clean. Debt-to-equity is only about 0.04, current ratio 2.3, and cash and short-term investments total roughly $1.28B. For traders, that means PATH has room to keep funding AI product pushes and sales efforts without leaning on dilutive capital raises. The intraday 5‑minute chart on 2026/09/14 shows a steady grind from around $14.00 in premarket to the high $14.70s midday, signaling dip buyers quietly soaking up supply after the selloff.

Why Traders Are Watching PATH After The Post-Earnings Flush

PATH gave the market a classic “good numbers, bad reaction” setup. UiPath beat on Q2 revenue at $410.3M versus roughly $398M consensus, held non-GAAP EPS flat at $0.15 in line with expectations, and raised full-year FY27 revenue guidance to $1.789B–$1.794B. Management also lifted ARR guidance to $2.065B–$2.07B. That is not hyper-growth, but it is solid mid-teens expansion with real profits attached.

Yet the stock still took a sharp hit — about 14% on one post-earnings day, according to Oppenheimer’s read — then saw another roughly 6% drop tied to leadership changes, including promoting long-time finance leader Hitesh Ramani to CFO and shifting Ashim Gupta fully into the COO seat. For short-term PATH traders, that disconnect between fundamentals and price creates opportunity, but also noise.

On the positive side, Wall Street is leaning more constructive. RBC Capital, BMO Capital, and Barclays all bumped their PATH price targets up (to roughly $17–$18) after the print, citing a beat-and-raise quarter, AI-driven deal momentum, and improving large-enterprise traction. Citi went further, initiating coverage with a Buy rating and a $23 target, arguing UiPath’s platform is evolving into a “control plane” for enterprise AI — the orchestration layer that makes disparate AI agents and workflows actually work in the real world.

UiPath is feeding that narrative. PATH rolled out Maestro Case and Maestro Flow to deepen its business orchestration story, released a global survey framing most enterprises as stuck in pilot-phase agentic AI, and pointed to scaled wins like PLDT in the Philippines, which is using UiPath’s AI and automation to improve telecom customer service and risk management. For traders, that means the story is not just buzzwords — there are real deployments tied to revenue and ARR growth.

Conclusion

PATH sits at an interesting crossroad. On one hand, UiPath just delivered 13% revenue growth, 12% ARR growth to $1.94B, gross margins above 80%, and positive GAAP and non-GAAP operating income, while nudging FY27 revenue and ARR guidance higher. The balance sheet is strong, the company is generating free cash flow (about $29.3M in the latest quarter), and leverage is minimal. That is solid footing for any AI automation name.

On the other hand, the market has punished PATH’s stock price in the short term, reflecting worries about growth re-acceleration, leadership transitions, and a still-choppy macro backdrop. Analyst target hikes from RBC, BMO, Barclays, and Citi’s bullish $23 call help sentiment, but they do not erase volatility. PATH remains a battleground between traders who see a durable AI orchestration leader and those who want more proof of sustained high growth.

For active traders, the playbook is to treat PATH like any volatile tech name with real numbers behind it: respect support and resistance, watch how the stock reacts around earnings, guidance, and big customer wins, and stay ready to cut fast if the story cracks. As millionaire penny stock trader and teacher Tim Sykes, says, “It’s not about how much money you make; it’s about how much money you keep.” As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your discipline.” This article is for educational and research purposes only and is not investment advice; use PATH’s fundamentals, news flow, and chart action as tools in your own trading process, not as a shortcut.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”